A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability

被引:99
作者
Patzel, V
Steidl, U
Kronenwett, R
Haas, R
Sczakiel, G
机构
[1] Deutsch Krebsforschungszentrum, Forsch Schwerpunkt Angew Tumorvirol, D-69120 Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum, Klin Kooperat Seinheit Mol Hamatol Onkol, D-69120 Heidelberg, Germany
[3] Univ Heidelberg, Med Klin & Poliklin 5, D-69115 Heidelberg, Germany
关键词
D O I
10.1093/nar/27.22.4328
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Up to now, out of approximately 20 antisense oligodeoxyribonucleotides (asODN) selected and tested against a given target gene, only one species shows substantial suppression of target gene expression. In part, this seems to be related to the general assumption that the structures of local target sequences or antisense nucleic acids are unfavorable for efficient annealing. Experimental approaches to find effective asODN are extremely expensive when including a large number of antisense species and when considering their moderate success. Here, we make use of a systematic alignment of computer-predicted secondary structures of local sequence stretches of the target RNA and of semi-empirical rules to identify favorable local target sequences and, hence, to design more effective asODN. The intercellular adhesion molecule 1 (ICAM-1) gene was chosen as a target because it had been shown earlier to be sensitive to antisense-mediated gene suppression. By applying the protocol described here, 10 ICAM-1-directed asODN species were found that showed substantially improved inhibition of target gene expression in the endothelial cell line ECV304 when compared with the most effective published asODN. Further, 17 out of 34 antisense species (50%) selected on the theoretical basis described here showed significant (>50%) inhibition of ICAM-1 expression in mammalian cells.
引用
收藏
页码:4328 / 4334
页数:7
相关论文
共 34 条
  • [1] BENNETT CF, 1994, J IMMUNOL, V152, P3530
  • [2] Bennett CF, 1997, J PHARMACOL EXP THER, V280, P988
  • [3] β2 integrin ICAM expression in Crohn's disease
    Bernstein, CN
    Sargent, P
    Gallatin, WM
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 86 (02): : 147 - 160
  • [4] Birikh KR, 1997, RNA, V3, P429
  • [5] PREDICTING DNA DUPLEX STABILITY FROM THE BASE SEQUENCE
    BRESLAUER, KJ
    FRANK, R
    BLOCKER, H
    MARKY, LA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) : 3746 - 3750
  • [6] CHIANG MY, 1991, J BIOL CHEM, V266, P18162
  • [7] DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090
  • [8] Implications of RNA structure on the annealing of a potent antisense RNA directed against the human immunodeficiency virus type 1
    Eckardt, S
    Romby, P
    Sczakiel, G
    [J]. BIOCHEMISTRY, 1997, 36 (42) : 12711 - 12721
  • [9] STATISTICS OF RNA SECONDARY STRUCTURES
    FONTANA, W
    KONINGS, DAM
    STADLER, PF
    SCHUSTER, P
    [J]. BIOPOLYMERS, 1993, 33 (09) : 1389 - 1404
  • [10] CHARACTERIZATION OF INTERCELLULAR-ADHESION MOLECULE-1 AND HLA-DR EXPRESSION IN NORMAL AND INFLAMED SKIN - MODULATION BY RECOMBINANT GAMMA INTERFERON AND TUMOR NECROSIS FACTOR
    GRIFFITHS, CEM
    VOORHEES, JJ
    NICKOLOFF, BJ
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (04) : 617 - 629